{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:53:26Z","timestamp":1795107206956,"version":"4.10.3"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001323","name":"Poliomyelitis Research Foundation","doi-asserted-by":"publisher","award":["22\/91"],"award-info":[{"award-number":["22\/91"]}],"id":[{"id":"10.13039\/501100001323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>HIV-1 remains a global health concern and to date, nearly 38 million people are living with HIV. The complexity of HIV-1 pathogenesis and its subsequent prevalence is influenced by several factors including the HIV-1 subtype. HIV-1 subtype variation extends to sequence variation in the amino acids of the HIV-1 viral proteins. Of particular interest is the transactivation of transcription (Tat) protein due to its key function in viral transcription. The Tat protein predominantly functions by binding to the transactivation response (TAR) RNA element to activate HIV-1 transcriptional elongation. Subtype-specific Tat protein sequence variation influences Tat-TAR binding affinity. Despite several studies investigating Tat-TAR binding, it is not clear which regions of the Tat protein and\/or individual Tat amino acid residues may contribute to TAR binding affinity. We, therefore, conducted a scoping review on studies investigating Tat-TAR binding. We aimed to synthesize the published data to determine (1) the regions of the Tat protein that may be involved in TAR binding, (2) key Tat amino acids involved in TAR binding and (3) if Tat subtype-specific variation influences TAR binding. A total of thirteen studies met our inclusion criteria and the key findings were that (1) both N-terminal and C-terminal amino acids outside the basic domain (47\u201359) may be important in increasing Tat-TAR binding affinity, (2) substitution of the amino acids Lysine and Arginine (47\u201359) resulted in a reduction in binding affinity to TAR, and (3) none of the included studies have investigated Tat subtype-specific substitutions and therefore no commentary could be made regarding which subtype may have a higher Tat-TAR binding affinity. Future studies investigating Tat-TAR binding should therefore use full-length Tat proteins and compare subtype-specific variations. Studies of such a nature may help explain why we see differential pathogenesis and prevalence when comparing HIV-1 subtypes.<\/jats:p>","DOI":"10.1186\/s12879-023-08123-0","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:03:10Z","timestamp":1679029390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["HIV-1 Tat amino acid residues that influence Tat-TAR binding affinity: a scoping review"],"prefix":"10.1186","volume":"23","author":[{"given":"Piwai Terry","family":"Gotora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rencia","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monray Edward","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"issue":"1","key":"8123_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0042-6822(87)90449-1","volume":"156","author":"HR Gelderblom","year":"1987","unstructured":"Gelderblom HR, Hausmann EH, \u00d6zel M, Pauli G, Koch MA. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology. 1987;156(1):171\u20136.","journal-title":"Virology"},{"issue":"1","key":"8123_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/bmb\/58.1.7","volume":"58","author":"L Morison","year":"2001","unstructured":"Morison L. The global epidemiology of HIV\/AIDS. Br Med Bull. 2001;58(1):7\u201318.","journal-title":"Br Med Bull"},{"issue":"4599","key":"8123_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.6189183","volume":"220","author":"F Barr\u00e9-Sinoussi","year":"1983","unstructured":"Barr\u00e9-Sinoussi F, Chermann J-C, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, V\u00e9zinet-Brun F, Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220(4599):868\u201371.","journal-title":"Science"},{"issue":"1","key":"8123_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-10013-y","volume":"21","author":"JF Montana","year":"2021","unstructured":"Montana JF, Ferreira GRON, Cunha CLF, de Queiroz AAR, Fernandes WAA, Polaro SHI, Gon\u00e7alves LHT, Couto DCC, Gir E, Reis RK. The HIV epidemic in Colombia: spatial and temporal trends analysis. BMC Public Health. 2021;21(1):1\u201314.","journal-title":"BMC Public Health"},{"key":"8123_CR5","unstructured":"UNAIDS. Danger: UNAIDS global AIDS update 2022. In: 2022."},{"issue":"3","key":"8123_CR6","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S2352-3018(20)30359-3","volume":"8","author":"J Dorward","year":"2021","unstructured":"Dorward J, Khubone T, Gate K, Ngobese H, Sookrajh Y, Mkhize S, Jeewa A, Bottomley C, Lewis L, Baisley K, et al. The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis. Lancet HIV. 2021;8(3):e158\u201365.","journal-title":"Lancet HIV"},{"issue":"1","key":"8123_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-021-00335-1","volume":"18","author":"S Gatechompol","year":"2021","unstructured":"Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes DR. COVID-19 and HIV infection co-pandemics and their impact: a review of the literature. AIDS Res Ther. 2021;18(1):1\u20139.","journal-title":"AIDS Res Ther"},{"issue":"7","key":"8123_CR8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.chom.2021.05.012","volume":"29","author":"W Fischer","year":"2021","unstructured":"Fischer W, Giorgi EE, Chakraborty S, Nguyen K, Bhattacharya T, Theiler J, Goloboff PA, Yoon H, Abfalterer W, Foley BT, et al. HIV-1 and SARS-CoV-2: patterns in the evolution of two pandemic pathogens. Cell Host Microbe. 2021;29(7):1093\u2013110.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"8123_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/rmv.1739","volume":"23","author":"S Nyamweya","year":"2013","unstructured":"Nyamweya S, Hegedus A, Jaye A, Rowland-Jones S, Flanagan KL, Macallan DC. Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis. Rev Med Virol. 2013;23(4):221\u201340.","journal-title":"Rev Med Virol"},{"issue":"11","key":"8123_CR10","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1016\/S2352-3018(20)30252-6","volume":"7","author":"J Hemelaar","year":"2020","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Kirtley S, Gouws-Williams E, Ghys PD, Alash\u2019le GA, Agwale S, Archibald C. Global and regional epidemiology of HIV-1 recombinants in 1990\u20132015: a systematic review and global survey. Lancet HIV. 2020;7(11):e772\u201381.","journal-title":"Lancet HIV"},{"issue":"15","key":"8123_CR11","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1056\/NEJMra0706737","volume":"358","author":"BS Taylor","year":"2008","unstructured":"Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. The challenge of HIV-1 subtype diversity. N Engl J Med. 2008;358(15):1590\u2013602.","journal-title":"N Engl J Med"},{"key":"8123_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102682","volume":"53","author":"MJ Gartner","year":"2020","unstructured":"Gartner MJ, Roche M, Churchill MJ, Gorry PR, Flynn JK. Understanding the mechanisms driving the spread of subtype C HIV-1. EBioMedicine. 2020;53: 102682.","journal-title":"EBioMedicine"},{"issue":"3","key":"8123_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/COH.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14(3):153\u201360.","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"8123_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","volume":"19","author":"J Hemelaar","year":"2019","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019;19(2):143\u201355.","journal-title":"Lancet Infect Dis"},{"key":"8123_CR15","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1097\/00002030-200406003-00012","volume":"18","author":"MA Wainberg","year":"2004","unstructured":"Wainberg MA. HIV-1 subtype distribution and the problem of drug resistance. AIDS. 2004;18:S63\u20138.","journal-title":"AIDS"},{"issue":"16","key":"8123_CR16","doi-asserted-by":"publisher","first-page":"W13","DOI":"10.1097\/01.aids.0000247564.73009.bc","volume":"20","author":"J Hemelaar","year":"2006","unstructured":"Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;20(16):W13\u201323.","journal-title":"AIDS"},{"issue":"5","key":"8123_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/QAD.0b013e328342ff93","volume":"25","author":"J Hemelaar","year":"2011","unstructured":"Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000\u20132007. AIDS. 2011;25(5):679.","journal-title":"AIDS"},{"issue":"2","key":"8123_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/088922200309485","volume":"16","author":"K Triques","year":"2000","unstructured":"Triques K, Bourgeois A, Vidal N, Mpoudi-Ngole E, Mulanga-Kabeya C, Nzilambi N, Torimiro N, Saman E, Delaporte E, Peeters M. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses. 2000;16(2):139\u201351.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"8123_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/0-306-47817-X_12","volume-title":"AIDS in Africa","author":"P Piot","year":"2002","unstructured":"Piot P, Bartos M. The epidemiology of HIV and AIDS. In: Essex M, Mboup S, Kanki PJ, Marlink RG, Tlou SD, Holme M, editors. AIDS in Africa. Boston: Springer; 2002. p. 200\u201317."},{"issue":"19","key":"8123_CR20","doi-asserted-by":"publisher","first-page":"10209","DOI":"10.1128\/JVI.00872-07","volume":"81","author":"L Buonaguro","year":"2007","unstructured":"Buonaguro L, Tornesello M, Buonaguro F. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol. 2007;81(19):10209\u201319.","journal-title":"J Virol"},{"issue":"5","key":"8123_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3851\/IMP3024","volume":"21","author":"V Calvez","year":"2016","unstructured":"Calvez V, Marcelin A-G, Vingerhoets J, Hill A, Hadacek B, Moecklinghoff C. Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons. Antivir Ther. 2016;21(5):405\u201312.","journal-title":"Antivir Ther"},{"key":"8123_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-9610-6_60-1","author":"F Kirchhoff","year":"2013","unstructured":"Kirchhoff F. HIV life cycle: overview. Encyclopedia AIDS. 2013. https:\/\/doi.org\/10.1007\/978-1-4614-9610-6_60-1.","journal-title":"Encyclopedia AIDS"},{"issue":"1","key":"8123_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-7-82","volume":"7","author":"JM Doolittle","year":"2010","unstructured":"Doolittle JM, Gomez SM. Structural similarity-based predictions of protein interactions between HIV-1 and Homo sapiens. Virol J. 2010;7(1):1\u201315.","journal-title":"Virol J"},{"key":"8123_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biochem.67.1.1","volume":"67","author":"AD Frankel","year":"1998","unstructured":"Frankel AD, Young JA. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem. 1998;67:1\u201325.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"8123_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cbf.1147","volume":"23","author":"A Pugliese","year":"2005","unstructured":"Pugliese A, Vidotto V, Beltramo T, Petrini S, Torre D. A review of HIV-1 Tat protein biological effects. Cell Biochem Funct. 2005;23(4):223\u20137.","journal-title":"Cell Biochem Funct"},{"key":"8123_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1742-4690-3-53","volume":"3","author":"NB Siddappa","year":"2006","unstructured":"Siddappa NB, Venkatramanan M, Venkatesh P, Janki MV, Jayasuryan N, Desai A, Ravi V, Ranga U. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology. 2006;3:53.","journal-title":"Retrovirology"},{"issue":"13","key":"8123_CR27","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1074\/jbc.M510748200","volume":"281","author":"S Shojania","year":"2006","unstructured":"Shojania S, O\u2019Neil JD. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1\u201372) by NMR spectroscopy. J Biol Chem. 2006;281(13):8347\u201356.","journal-title":"J Biol Chem"},{"issue":"9","key":"8123_CR28","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1093\/nar\/17.9.3551","volume":"17","author":"M Kuppuswamy","year":"1989","unstructured":"Kuppuswamy M, Subramanian T, Srinivasan A, Chinnadurai G. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 1989;17(9):3551\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"8123_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-6-50","volume":"6","author":"GR Campbell","year":"2009","unstructured":"Campbell GR, Loret EP. What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology. 2009;6(1):1\u201313.","journal-title":"Retrovirology"},{"issue":"41","key":"8123_CR30","doi-asserted-by":"publisher","first-page":"28837","DOI":"10.1074\/jbc.274.41.28837","volume":"274","author":"K-T Jeang","year":"1999","unstructured":"Jeang K-T, Xiao H, Rich EA. Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J Biol Chem. 1999;274(41):28837\u201340.","journal-title":"J Biol Chem"},{"issue":"2","key":"8123_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2031","volume":"29","author":"MA Kurnaeva","year":"2019","unstructured":"Kurnaeva MA, Sheval EV, Musinova YR, Vassetzky YS. Tat basic domain: a \u201cSwiss army knife\u201d of HIV-1 Tat? Rev Med Virol. 2019;29(2): e2031.","journal-title":"Rev Med Virol"},{"key":"8123_CR32","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3389\/fmicb.2015.01164","volume":"6","author":"S Mediouni","year":"2015","unstructured":"Mediouni S, Marcondes MC, Miller C, McLaughlin JP, Valente ST. The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders. Front Microbiol. 2015;6:1164.","journal-title":"Front Microbiol"},{"issue":"6","key":"8123_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/bip.10000","volume":"62","author":"C Gr\u00e9goire","year":"2001","unstructured":"Gr\u00e9goire C, P\u00e9lopon\u00e8se JM Jr, Esquieu D, Opi S, Campbell G, Solomiac M, Lebrun E, Lebreton J, Loret EP. Homonuclear 1H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers. 2001;62(6):324\u201335.","journal-title":"Biopolymers."},{"issue":"1","key":"8123_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-5-83","volume":"5","author":"JD Watkins","year":"2008","unstructured":"Watkins JD, Campbell GR, Halimi H, Loret EP. Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology. 2008;5(1):1\u201311.","journal-title":"Retrovirology"},{"issue":"19","key":"8123_CR35","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1073\/pnas.86.19.7397","volume":"86","author":"AD Frankel","year":"1989","unstructured":"Frankel AD, Biancalana S, Hudson D. Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 1989;86(19):7397\u2013401.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8123_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1006\/jmbi.1993.1128","volume":"230","author":"MJ Churcher","year":"1993","unstructured":"Churcher MJ, Lamont C, Hamy F, Dingwall C, Green SM, Lowe AD, Butler PJG, Gait MJ, Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J Mol Biol. 1993;230(1):90\u2013110.","journal-title":"J Mol Biol"},{"issue":"3","key":"8123_CR37","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1128\/jvi.63.3.1181-1187.1989","volume":"63","author":"J Hauber","year":"1989","unstructured":"Hauber J, Malim MH, Cullen BR. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol. 1989;63(3):1181\u20137.","journal-title":"J Virol"},{"issue":"8","key":"8123_CR38","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1074\/jbc.M007540200","volume":"276","author":"S Futaki","year":"2001","unstructured":"Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 2001;276(8):5836\u201340.","journal-title":"J Biol Chem."},{"issue":"5","key":"8123_CR39","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1074\/jbc.M006701200","volume":"276","author":"M Tyagi","year":"2001","unstructured":"Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem. 2001;276(5):3254\u201361.","journal-title":"J Biol Chem"},{"issue":"1","key":"8123_CR40","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1038\/s41598-019-39531-5","volume":"9","author":"AP Ruiz","year":"2019","unstructured":"Ruiz AP, Ajasin DO, Ramasamy S, DesMarais V, Eugenin EA, Prasad VR. A naturally occurring polymorphism in the HIV-1 Tat basic domain inhibits uptake by bystander cells and leads to reduced neuroinflammation. Sci Rep. 2019;9(1):3308.","journal-title":"Sci Rep"},{"issue":"2","key":"8123_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1570162X12666141202125643","volume":"13","author":"E Loret","year":"2015","unstructured":"Loret E. HIV extracellular Tat: myth or reality? Curr HIV Res. 2015;13(2):90\u20137.","journal-title":"Curr HIV Res"},{"issue":"5","key":"8123_CR42","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.micinf.2005.11.014","volume":"8","author":"JE King","year":"2006","unstructured":"King JE, Eugenin EA, Buckner CM, Berman JW. HIV tat and neurotoxicity. Microbes Infect. 2006;8(5):1347\u201357.","journal-title":"Microbes Infect"},{"issue":"3","key":"8123_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1189\/jlb.0607405","volume":"83","author":"U Mahlknecht","year":"2008","unstructured":"Mahlknecht U, Dichamp I, Varin A, Van Lint C, Herbein G. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. J Leukoc Biol. 2008;83(3):718\u201327.","journal-title":"J Leukoc Biol"},{"issue":"6 Pt 1","key":"8123_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/BF02256316","volume":"10","author":"C Neuveut","year":"2003","unstructured":"Neuveut C, Scoggins RM, Camerini D, Markham RB, Jeang KT. Requirement for the second coding exon of Tat in the optimal replication of macrophage-tropic HIV-1. J Biomed Sci. 2003;10(6 Pt 1):651\u201360.","journal-title":"J Biomed Sci"},{"issue":"4708","key":"8123_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.2990041","volume":"229","author":"J Sodroski","year":"1985","unstructured":"Sodroski J, Patarca R, Rosen C, Wong-Staal F, Haseltine W. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. Science. 1985;229(4708):74\u20137.","journal-title":"Science"},{"issue":"3","key":"8123_CR46","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1083\/jcb.111.3.1275","volume":"111","author":"DA Brake","year":"1990","unstructured":"Brake DA, Debouck C, Biesecker G. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J Cell Biol. 1990;111(3):1275\u201381.","journal-title":"J Cell Biol"},{"issue":"17","key":"8123_CR47","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1073\/pnas.90.17.7941","volume":"90","author":"G Barillari","year":"1993","unstructured":"Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA. 1993;90(17):7941\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8123_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fmicb.2017.00080","volume":"8","author":"D Kamori","year":"2017","unstructured":"Kamori D, Ueno T. HIV-1 Tat and viral latency: what we can learn from naturally occurring sequence variations. Front Microbiol. 2017;8:80.","journal-title":"Front Microbiol"},{"issue":"2","key":"8123_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00430-019-00583-z","volume":"208","author":"C Spector","year":"2019","unstructured":"Spector C, Mele AR, Wigdahl B, Nonnemacher MR. Genetic variation and function of the HIV-1 Tat protein. Med Microbiol Immunol. 2019;208(2):131\u201369.","journal-title":"Med Microbiol Immunol"},{"key":"8123_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104701","volume":"136","author":"ME Williams","year":"2020","unstructured":"Williams ME, Zulu SS, Stein DJ, Joska JA, Naud\u00e9 PJW. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments. Neurobiol Dis. 2020;136: 104701.","journal-title":"Neurobiol Dis"},{"issue":"46","key":"8123_CR51","doi-asserted-by":"publisher","first-page":"48197","DOI":"10.1074\/jbc.M406195200","volume":"279","author":"GR Campbell","year":"2004","unstructured":"Campbell GR, Pasquier E, Watkins J, Bourgarel-Rey V, Peyrot V, Esquieu D, Barbier P, de Mareuil J, Braguer D, Kaleebu P. The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J Biol Chem. 2004;279(46):48197\u2013204.","journal-title":"J Biol Chem"},{"issue":"12","key":"8123_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082128","volume":"8","author":"S Lata","year":"2013","unstructured":"Lata S, Ronsard L, Sood V, Dar SA, Ramachandran VG, Das S, Banerjea AC. Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India. PLoS ONE. 2013;8(12): e82128.","journal-title":"PLoS ONE"},{"issue":"1","key":"8123_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13365-020-00935-z","volume":"27","author":"SM de Almeida","year":"2021","unstructured":"de Almeida SM, Rotta I, Vidal LRR, Dos Santos JS, Nath A, Johnson K, Letendre S, Ellis RJ. HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil. J Neurovirol. 2021;27(1):126\u201336.","journal-title":"J Neurovirol"},{"issue":"11","key":"8123_CR54","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1348-0421.2002.tb02766.x","volume":"46","author":"T Kurosu","year":"2002","unstructured":"Kurosu T, Mukai T, Komoto S, Ibrahim MS, Li YG, Kobayashi T, Tsuji S, Ikuta K. Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E. Microbiol Immunol. 2002;46(11):787\u201399.","journal-title":"Microbiol Immunol"},{"issue":"7","key":"8123_CR55","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/jmv.27720","volume":"94","author":"ME Williams","year":"2022","unstructured":"Williams ME, Ruhanya V, Paul RH, Ipser JC, Stein DJ, Joska JA, Naud\u00e9 PJW. An investigation of the HIV Tat C31S and R57S mutation on peripheral immune marker levels in South African participants: A pilot study. J Med Virol. 2022;94(7):2936\u20138.","journal-title":"J Med Virol"},{"issue":"2","key":"8123_CR56","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.expneurol.2009.07.005","volume":"219","author":"MY Aksenov","year":"2009","unstructured":"Aksenov MY, Aksenova MV, Mactutus CF, Booze RM. Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures. Exp Neurol. 2009;219(2):586\u201390.","journal-title":"Exp Neurol"},{"issue":"6","key":"8123_CR57","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1128\/JVI.06648-11","volume":"86","author":"DA Donahue","year":"2012","unstructured":"Donahue DA, Kuhl BD, Sloan RD, Wainberg MA. The viral protein Tat can inhibit the establishment of HIV-1 latency. J Virol. 2012;86(6):3253\u201363.","journal-title":"J Virol"},{"issue":"30","key":"8123_CR58","doi-asserted-by":"publisher","first-page":"12407","DOI":"10.1002\/anie.202003461","volume":"59","author":"R Paul","year":"2020","unstructured":"Paul R, Dutta D, Paul R, Dash J. Target-directed azide-alkyne cycloaddition for assembling HIV-1 TAR RNA binding ligands. Angew Chem Int Ed Engl. 2020;59(30):12407\u201311.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"24","key":"8123_CR59","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1007\/s00018-020-03561-4","volume":"77","author":"J Marino","year":"2020","unstructured":"Marino J, Maubert ME, Mele AR, Spector C, Wigdahl B, Nonnemacher MR. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND. Cell Mol Life Sci. 2020;77(24):5079\u201399.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"8123_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/jmbi.1999.3060","volume":"293","author":"J Karn","year":"1999","unstructured":"Karn J. Tackling tat. J Mol Biol. 1999;293(2):235\u201354.","journal-title":"J Mol Biol"},{"issue":"28","key":"8123_CR61","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.2174\/1381612823666170704130635","volume":"23","author":"AP Rice","year":"2017","unstructured":"Rice AP. The HIV-1 Tat protein: mechanism of action and target for HIV-1 cure strategies. Curr Pharm Des. 2017;23(28):4098\u2013102.","journal-title":"Curr Pharm Des"},{"issue":"23","key":"8123_CR62","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1016\/j.bpj.2021.11.006","volume":"120","author":"S Ning","year":"2021","unstructured":"Ning S, Zeng C, Zeng C, Zhao Y. The TAR binding dynamics and its implication in Tat degradation mechanism. Biophys J. 2021;120(23):5158\u201368.","journal-title":"Biophys J"},{"issue":"14","key":"8123_CR63","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1128\/MCB.23.14.4859-4869.2003","volume":"23","author":"AA Michels","year":"2003","unstructured":"Michels AA, Nguyen VT, Fraldi A, Labas V, Edwards M, Bonnet F, Lania L, Bensaude O. MAQ1 and 7SK RNA interact with CDK9\/cyclin T complexes in a transcription-dependent manner. Mol Cell Biol. 2003;23(14):4859\u201369.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"8123_CR64","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S1097-2765(03)00388-5","volume":"12","author":"JH Yik","year":"2003","unstructured":"Yik JH, Chen R, Nishimura R, Jennings JL, Link AJ, Zhou Q. Inhibition of P-TEFb (CDK9\/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol Cell. 2003;12(4):971\u201382.","journal-title":"Mol Cell"},{"issue":"1","key":"8123_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.016303-0","volume":"91","author":"B Romani","year":"2010","unstructured":"Romani B, Engelbrecht S, Glashoff RH. Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol. 2010;91(1):1\u201312.","journal-title":"J Gen Virol"},{"issue":"1","key":"8123_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1006\/jmbi.1993.1129","volume":"230","author":"F Hamy","year":"1993","unstructured":"Hamy F, Asseline U, Grasby J, Iwai S, Pritchard C, Slim G, Butler PJ, Karn J, Gait MJ. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA. J Mol Biol. 1993;230(1):111\u201323.","journal-title":"J Mol Biol"},{"key":"8123_CR67","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3389\/fmicb.2017.01467","volume":"8","author":"L Ronsard","year":"2017","unstructured":"Ronsard L, Rai T, Rai D, Ramachandran VG, Banerjea AC. In silico analyses of subtype specific HIV-1 Tat-TAR RNA interaction reveals the structural determinants for viral activity. Front Microbiol. 2017;8:1467.","journal-title":"Front Microbiol"},{"issue":"5","key":"8123_CR68","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0022-2836(02)00217-6","volume":"318","author":"S Pantano","year":"2002","unstructured":"Pantano S, Tyagi M, Giacca M, Carloni P. Amino acid modification in the HIV-1 Tat basic domain: insights from molecular dynamics and in vivo functional studies. J Mol Biol. 2002;318(5):1331\u20139.","journal-title":"J Mol Biol"},{"issue":"2","key":"8123_CR69","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1101\/gad.5.2.201","volume":"5","author":"BJ Calnan","year":"1991","unstructured":"Calnan BJ, Biancalana S, Hudson D, Frankel AD. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes Dev. 1991;5(2):201\u201310.","journal-title":"Genes Dev"},{"issue":"1","key":"8123_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/bbrc.1997.7770","volume":"241","author":"AU Metzger","year":"1997","unstructured":"Metzger AU, Bayer P, Willbold D, Hoffmann S, Frank RW, Goody RS, R\u00f6sch P. The interaction of HIV-1 Tat (32\u201372) with its target RNA: a fluorescence and nuclear magnetic resonance study. Biochem Biophys Res Commun. 1997;241(1):31\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"8123_CR71","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1073\/pnas.90.4.1571","volume":"90","author":"J Tao","year":"1993","unstructured":"Tao J, Frankel AD. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins. Proc Natl Acad Sci. 1993;90(4):1571\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"8123_CR72","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1074-5521(02)00150-3","volume":"9","author":"TE Edwards","year":"2002","unstructured":"Edwards TE, Okonogi TM, Sigurdsson ST. Investigation of RNA-protein and RNA-metal ion interactions by electron paramagnetic resonance spectroscopy. The HIV TAR-Tat motif. Chem Biol. 2002;9(6):699\u2013706.","journal-title":"Chem Biol"},{"key":"8123_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/164_2019_284","volume":"257","author":"CH Emmerich","year":"2019","unstructured":"Emmerich CH, Harris CM. Minimum information and quality standards for conducting, reporting, and organizing in vitro research. Handb Exp Pharmacol. 2019;257:177\u201396.","journal-title":"Handb Exp Pharmacol"},{"issue":"140","key":"8123_CR74","first-page":"55","volume":"22","author":"R Likert","year":"1932","unstructured":"Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22(140):55\u201355.","journal-title":"Arch Psychol"},{"issue":"3","key":"8123_CR75","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"issue":"2","key":"8123_CR76","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1021\/bc050277u","volume":"17","author":"H Cao","year":"2006","unstructured":"Cao H, Tamilarasu N, Rana TM. Orientation and affinity of HIV-1 Tat fragments in Tat\u2014TAR complex determined by fluorescence resonance energy transfer. Bioconjug Chem. 2006;17(2):352\u20138.","journal-title":"Bioconjug Chem"},{"issue":"3","key":"8123_CR77","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0301-4622(03)00155-8","volume":"106","author":"N Tassew","year":"2003","unstructured":"Tassew N, Thompson M. Kinetic characterization of TAR RNA\u2013Tat peptide and neomycin interactions by acoustic wave biosensor. Biophys Chem. 2003;106(3):241\u201352.","journal-title":"Biophys Chem"},{"issue":"4974","key":"8123_CR78","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.2205002","volume":"249","author":"KM Weeks","year":"1990","unstructured":"Weeks KM, Ampe C, Schultz SC, Steitz TA, Crothers DM. Fragments of the HIV-1 Tat protein specifically biand TAR RNA. Science. 1990;249(4974):1281\u20135.","journal-title":"Science"},{"issue":"3","key":"8123_CR79","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12640-009-9047-8","volume":"16","author":"W Li","year":"2009","unstructured":"Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox Res. 2009;16(3):205\u201320.","journal-title":"Neurotox Res"},{"issue":"22","key":"8123_CR80","doi-asserted-by":"publisher","first-page":"8985","DOI":"10.1073\/pnas.87.22.8985","volume":"87","author":"MG Cordingley","year":"1990","unstructured":"Cordingley MG, LaFemina RL, Callahan PL, Condra JH, Sardana VV, Graham DJ, Nguyen TM, LeGrow K, Gotlib L, Schlabach AJ. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci. 1990;87(22):8985\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"8123_CR81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00018-004-4477-1","volume":"62","author":"O Chaloin","year":"2005","unstructured":"Chaloin O, Peter J-C, Briand J-P, Masquida B, Desgranges C, Muller S, Hoebeke J. The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction. Cell Mol Life Sci. 2005;62:355\u201361.","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"8123_CR82","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0960-894X(00)00359-0","volume":"10","author":"C Matsumoto","year":"2000","unstructured":"Matsumoto C, Hamasaki K, Mihara H, Ueno A. A high-throughput screening utilizing intramolecular fluorescence resonance energy transfer for the discovery of the molecules that bind HIV-1 TAR RNA specifically. Bioorg Med Chem Lett. 2000;10(16):1857\u201361.","journal-title":"Bioorg Med Chem Lett"},{"issue":"27","key":"8123_CR83","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1021\/bi00027a041","volume":"34","author":"KS Long","year":"1995","unstructured":"Long KS, Crothers DM. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA. Biochemistry. 1995;34(27):8885\u201395.","journal-title":"Biochemistry"},{"issue":"20","key":"8123_CR84","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1021\/ol034977v","volume":"5","author":"MA Gelman","year":"2003","unstructured":"Gelman MA, Richter S, Cao H, Umezawa N, Gellman SH, Rana TM. Selective binding of TAR RNA by a Tat-derived \u03b2-peptide. Org Lett. 2003;5(20):3563\u20135.","journal-title":"Org Lett"},{"issue":"16","key":"8123_CR85","doi-asserted-by":"publisher","first-page":"8950","DOI":"10.1073\/pnas.160252097","volume":"97","author":"GA Weiss","year":"2000","unstructured":"Weiss GA, Watanabe CK, Zhong A, Goddard A, Sidhu SS. Rapid mapping of protein functional epitopes by combinatorial alanine scanning. Proc Natl Acad Sci. 2000;97(16):8950\u20134.","journal-title":"Proc Natl Acad Sci"},{"issue":"26","key":"8123_CR86","doi-asserted-by":"publisher","first-page":"7171","DOI":"10.1073\/pnas.1521349113","volume":"113","author":"AN Borkar","year":"2016","unstructured":"Borkar AN, Bardaro MF, Camilloni C, Aprile FA, Varani G, Vendruscolo M. Structure of a low-population binding intermediate in protein-RNA recognition. Proc Natl Acad Sci. 2016;113(26):7171\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"8123_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2019.197727","volume":"272","author":"RW Link","year":"2019","unstructured":"Link RW, Mele AR, Antell GC, Pirrone V, Zhong W, Kercher K, Passic S, Szep Z, Malone K, Jacobson JM. Investigating the distribution of HIV-1 Tat lengths present in the Drexel medicine CARES cohort. Virus Res. 2019;272: 197727.","journal-title":"Virus Res"},{"issue":"18","key":"8123_CR88","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1073\/pnas.87.18.7030","volume":"87","author":"J Jeyapaul","year":"1990","unstructured":"Jeyapaul J, Reddy MR, Khan SA. Activity of synthetic tat peptides in human immunodeficiency virus type 1 long terminal repeat-promoted transcription in a cell-free system. Proc Natl Acad Sci. 1990;87(18):7030\u20134.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"8123_CR89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/jnr.490420105","volume":"42","author":"B Weeks","year":"1995","unstructured":"Weeks B, Lieberman D, Johnson B, Roque E, Green M, Loewenstein P, Oldfield E, Kleinman H. Neurotoxicity of the human immunodeficiency virus type 1 Tat transactivator to PC12 cells requires the Tat amino acid 49\u201358 basic domain. J Neurosci Res. 1995;42(1):34\u201340.","journal-title":"J Neurosci Res"},{"issue":"2\u20133","key":"8123_CR90","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/bip.20174","volume":"80","author":"L Moroder","year":"2005","unstructured":"Moroder L, Musiol HJ, G\u00f6tz M, Renner C. Synthesis of single- and multiple-stranded cystine-rich peptides. Biopolymers. 2005;80(2\u20133):85\u201397.","journal-title":"Biopolymers"},{"issue":"3","key":"8123_CR91","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/v12030297","volume":"12","author":"JY Yeo","year":"2020","unstructured":"Yeo JY, Goh GR, Su CT, Gan SK. The Determination of HIV-1 RT mutation rate, its possible allosteric effects, and its implications on drug resistance. Viruses. 2020;12(3):297.","journal-title":"Viruses"},{"key":"8123_CR92","doi-asserted-by":"publisher","first-page":"866611","DOI":"10.3389\/fmicb.2022.866611","volume":"13","author":"ME Williams","year":"2022","unstructured":"Williams ME, Cloete R. Molecular modeling of subtype-specific Tat protein signatures to predict Tat-TAR interactions that may be involved in HIV-associated neurocognitive disorders. Front Microbiol. 2022;13:866611\u2013866611.","journal-title":"Front Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08123-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08123-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08123-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:03:51Z","timestamp":1679029431000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08123-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8123"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08123-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}